Explorez tous les épisodes du podcast The Poison Lab
Plongez dans la liste complète des épisodes de The Poison Lab. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.
Rows per page:
50
1–50 of 81
Titre
Date
Durée
LIVE from Denver: 2024 NACCT Research Review – Insights from the North American Congress of Clinical Toxicology
04 oct. 2024
01:22:53
In this exciting live episode from the 2024 North American Congress of Clinical Toxicology (NACCT) in Denver, Ryan dives into 12 of the most impactful research abstracts presented at the conference directly with the authors themselves. Covering a wide range of toxicology topics—from the NACSTOP2 trial on acetaminophen overdose, ECG intervals, cannabis toxicity in young children, and more—each guest breaks down their study’s findings and clinical relevance. If you missed the conference or want a deeper understanding of the year's most important toxicology research, this episode is for you. Check the show notes for links to the published abstracts, the full list of studies discussed, and time stamps for where you can find those studies.
07:48-Abstract #1. The NACSTOP2 trial: a multi-center randomized controlled trial investigating the early cessation of n-acetylcysteine in acetaminophen overdose
Guest- Dr. Anslem Wong, MD, PhD
21:33- Abstract #36. ECG intervals: does one size really fit all?
Guest- Dr. Caitlin Roake, MD, PhD
25:41- Abstract #85. Do abnormal electrocardiographic intervals predict death in poisoned patients older than 65 years?
Guest- Dr. Michael Chary, MD
30:06- Abstract #61. Minimum tetrahydrocannabinol dose that produces severe symptoms in children <6 years old with
cannabis edible ingestions
Guest- Dr. Keahi Horowitz, MD
36:25- Abstract #114. Frequency and severity of cannabis toxicity before and after legislative change to increase cannabis edible package size
Guest- Dr. Robert Hendrickson, MD
38:24- Abstract #101. Quantification of acetaminophen line-crossers in the setting o f overdose with delayed gastric absorption
Guest- Dr. Jamie Sterr, PharmD
41:41- Abstract #175. Cause for pause: bradycardia induced by transdermal rivastigmine in anticholinergic delirium
Guest- Dr. Santiago Batista Minaya, MD
46:21- Abstract #199. Cerebellar, hippocampal, and basal nuclei transient edema with restricted diffusion (CHANTER) Syndrome with poor neurological outcome in the setting of suspected opioid use
Guest- Jack Yang and Dr. Avery Michienzi, DO
49:49- 191. Severity scores for caustic injury: Zargar they even used?
Guest- Dr. Amar Chakrabortya, MD
53:!2- Abstract #9. Disparity in immune-mediated reactions to Crotalidae polyvalent immune fab (ovine) and Crotalidae immune F(ab’)2 [equine] in alpha-gal endemic regions and alpha-gal sensitized adults
Guest- Dr. Ari Filip, MD
59:10- Abstract # 26. Acute propranolol overdose and dose thresholds of severe toxicity
Guest- Dr. Katherine Isoardi, MBBS
1:06:05- 28. Risk of serotonin toxicity following acute lamotrigine overdose
Guest- Dr. Angela Chiew, MBBS, PhD (Introduction at 1:00:00)
1:12:36- Interview with AACT President Elect
Guest- Dr. Jillian Theobald, MD, PhD
The Poison Letter To The Editor: Listener Critiques and Author Responses for The AHA 2023 Life Threatening Poisoning Guidelines with Dr. Michael Mullins, Dr. Donna Seger, Dr. Leon Gussow, and Dr. Eric Lavonas
28 août 2024
00:23:47
In this episode the poison lab hosts scientific discourse . Three listeners (Dr. Michael Mullins, Dr. Donna Seger, and Dr. Leon Gussow) write in their critiques surrounding specific recommendations and language used with the AHA 2023 Management of Poisoning Cardiac Arrest or Life-Threatening Toxicity guidelines. Lead author of the guidelines Dr. Eric Lavonas then responds to and addresses their points with counterpoints or appraisals. Tune in and draw your own conclusions!
Have a burning question you have always wanted to ask a toxicologist? What are tips for managing an anticholinergic overdose? What is the deadliest poison? Why are they called lead pencils if there is no lead?! Send your questions in to toxtalk1@gmail.com to take part in a future episode! (If you would like to be anonymous simply state it in the email)
Open and Shut (Mystery case 31) with Guests Dr. Dan McCabe and Dr. Crissy Lawson
02 août 2024
01:42:35
In this episode Ryan is joined by two expert guests to help read listener guesses for the cause of this poisoning murder and shed light on the toxin involved in the case, which puzzled medicolegal investigators. Ryan is joined by Dr. Dan McCabe, MD (emergency medicine physician, medical toxicologist, medical director of Iowa poison center) and Dr. Crissy Lawson PharmD (emergency medicine pharmacist).
In this bonus episode Ryan highlights some of the great episodes done in 2023 and compiles ALL of the stump the toxicologist segments from 2023 into one easy to consume episode. Test your toxicology differential skills with more than six poisoning cases. Check out the actual episodes for more information in the show notes on each of the poisonings.
Episode #31 Mystery Case
14 juin 2024
00:01:53
Do you think you know the cause of these symptoms? Send your guesses to toxtalk1@gmail.com to take part in the next episode
Where is Episode #31 and Bonus Episodes- Ryan Joins "The Larry Meiller Radio Show" and The "EMS2020" Podcast
06 juin 2024
00:16:53
A quick update to share some other shows Ryan has been on in the last few weeks! Check the show notes for links to each episode!
Ryan on "The Larry Meiller Show" discussing delta cannabanoids
Bromazolam, Etonitazene, and Carfentanil Walk into a Bar – Trends in Novel Illicit Drugs with Dr. Alex Krotulski
01 mai 2024
01:41:48
In this episode Ryan interviews Dr. Alex Krotulski PhD from the Center for Forensic Science Research and Education. Together take a look at trends in novel opioids, benzodiazepines, stimulants, hallucinogens, synthetic cannabinoids, and "hemp products" that are showing up in your patients, drug products, and fatal overdoses. The conversation takes places around the Center for Forensic Science Research and Education quarterly report on Novel Psychoactive Substances found in patients and drug products.
The episode starts with a discussion of the novel benzodiazepines market, highlighting bromazolam and how long it may remain in the market. Then they discuss the opioids highlighting where we are seeing carfentanil, what is happening with Para Fluorofentanyl, and other super potent opioids emergening (such as N -pyrrolidino etonitazene). After a quick discussion of synthetic cathinone's and PCP/ketamine derivatives they jump to synthetic cannabinoids, examining the history of brodifacoum contamination and how regulation has led to market changes.
Novel psychedelics markets, hemp products, phenibut, tianeptine, and kratom-1:25:12
Inefficient Heat (Mystery Case 29) & Toxicologists vs The internet with Dr. Ann Arens
29 févr. 2024
01:35:06
Dr. Ann Arens, MD an emergency medicine physician and medical toxicologist with Oschner Medical center in New Orleans, LA joins the show to educate us on some HOT toxins, solve toxic cases, and opine on the philosophical and existential reasons drugs even exist. Tune in for a fantastic discussion with Dr. Arens and to hear the answer to our mystery case.
Do you think you know the cause of these symptoms? Send your guesses to toxtalk1@gmail.com to take part in episode 18
A very NACCT Holiday-2023 North American Congress of Clinical Toxicology High Yield Abstract Review
21 déc. 2023
01:34:00
In this episode Ryan is joined by a guest panel (Dr. Grant Comstock MD, Dr. Joshua Trebach MD, Dr. Emily Kiernan DO, and Dr Frank Paloucek PharmD, DABAT) to review nine of the most interesting or clinically impactful research abstracts that were presented at the 2023 North American Congress of Clinical Toxicology (NACCT) in Montreal Canada. If you didn't get a chance to read all 363 research abstracts from some of Toxicology's best and brightest this year, tune in for a high yield review as well as clinical a break down of the studies and their relevance from the expert panel.
Check the show notes for a link to the published abstracts and the list of all studies discussed in the show
10:40- Abstract 1 (PDF #225) Methotrexate toxicity in the setting of therapeutic error, a multicenter retrospective review
Lead author: Andrew Chambers
24:12- Abstract #2 (PDF #251) Oleander seeds in candlenut weight loss product strike again
Lead author: Masha Yemets
31:16- Abstract #3 (PDF #2) Efficacy of sodium tetrathionate when administered intramuscularly for the treatment of acute oral cyanide toxicity in a swine model (Sus scrofa)
Lead author: Brooke Lajeunesse
39:45- Abstract #4 (PDF #10) Is HOUR enough after out-of hospital naloxone for opioid overdose? Prospective preliminary data from real-world implementation of the modified St. Paul’s early discharge rule
Lead author: Stephen Douglas
49:05- Abstract #5- Poster titles at NACCT 2013–2022: is NACCT experiencing a pun-demic?
Lead author: Dayne Laskey
52:40- Rivastigmine discussion
Lead author: none
58:40- Abstract #6 (PDF #5) Randomized controlled trial of ANEB-001 as an antidote for acute cannabinoid intoxication in healthy adults
Lead author: Andrew Monte
1:08:00- Abstract #7 (PDF#216) Successful use of expired physostigmine to treat anticholinergic delirium in a pediatric patient
Lead author: Bryan Hayes
01:20:00- Abstract #8 (PDF #202) Enough negativity? Clinically significant salicylism with first detectable concentration twelve hours )post-ingestion
Lead author: Stacey Bangh
01:25:24 - Abstract #9 (PDF #267) High sensitivity troponin is frequently elevated after carbon monoxide exposure
Lead author: Abdullatif Aloumi
APAPalooza. A North American Congress of Clinical Toxicology 2023 Acetaminophen Research Highlight
19 nov. 2023
00:51:31
In this episode, Ryan dives into cutting-edge research on the treatment of acetaminophen (APAP) overdose, featuring interviews with authors of several key abstracts from the North American Congress of Clinical Toxicology (NACCT) in Montreal Canada (Abstracts and posters available in the show notes). We get first looks insights into research evaluating the impact of fomepizole high risk acetaminophen overdose, as well as who gets fomepizole for acetaminophen overdose and dies. Then we evaluate the effectiveness of standard N-acetylcysteine (NAC) treatment in high risk patients and high dose NAC in high risk patients. Join us for an insightful discussion on these advancements that are reshaping the management of APAP toxicity. Guests include Dr. Masha Yemets PharmD, Dr. Molly Stott PharmD, Dr. Alexandru Ulici PharmD, and Dr. Michael Moss MD.
(First guest) Abstract #126 Characterizing fomepizole use in acetaminophen deaths reported to US poison centers- Dr. Yemets
(Second guest) Abstract #125 Clinical impact of fomepizole as an adjunct therapy in massive acetaminophen overdose- Dr. Stott
(Third guest) Abstract #131 Comparison of low-risk and high risk acetaminophen ingestions using the standard prescott protocol of intravenous N-acetylcysteine- Dr. Ulici
(Fourth guest) Abstract #130 High-risk acetaminophen overdose outcomes after treatment with standard dose vs. increased dose N-acetylcysteine- Dr. Moss
AHA 2023 Management of Poisoning Cardiac Arrest or Life-Threatening Toxicity Guidelines with Co-Author Dr. Eric Lavonas MD
15 oct. 2023
00:50:38
In this episode, Ryan sits down with Dr. Eric Lavonas MD, a seasoned EM resuscitation guideline writer, emergency medicine physician, medical toxicologist, and lead author of the latest update to the American Heart Association's guidelines for the management of cardiac arrest and life-threatening toxicity due to poisoning. They have an in-depth discussion as they explore the key aspects of the 2023 AHA treatment recommendations and the rationale behind each decision point. A great review to discover how to effectively apply these guidelines in real-world scenarios and find out what knowledge gaps exist in the realm of toxin resuscitation. Be sure to also check out the accompanying mini-episode for a high-yield review of the major treatment recommendations.
High Yield Highlight- 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning
15 oct. 2023
00:15:30
In this episode Ryan does a high yield "just the facts" break down of the recently released "2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care". Tune in to learn about the most recent treatment recommendations made by AHA via a panel of toxicology experts. This was released alongside a full interview with the lead author Dr. Eric Lavonas MD. Be sure to check out the full interview to hear it straight from the source! (link in show notes).
The Poison Lab Does Psilocybin- A Deep Dive with Psilocybin Research Pharmacist Dr. Paul Hutson
20 sept. 2023
01:37:38
In this enlightening episode, Ryan engages in a deep conversation with Dr. Paul Hutson, PharmD, a renowned researcher in the field of psilocybin and director of the Transdisciplinary Center for Research in Psychoactive Substances at the University of Wisconsin Madison. Dr. Hutson shares his extensive knowledge and insights into the promising role of psilocybin in the treatment of depression and substance use disorder.
Throughout the discussion, they delve into the research that supports the use of psilocybin in medical therapy, shedding light on the rigorous processes involved in conducting such studies. Dr. Hutson elucidates the efficacy and safety findings that have emerged from his and others research, offering listeners a glimpse into the potential future of psilocybin in mainstream medical practices. Listeners will gain a deeper understanding of the meticulous approach to research that ensures both safety and effectiveness. Dr. Hutson shares firsthand experiences and observations, providing a rich and detailed perspective on the current state of psilocybin research. Moreover, the conversation ventures into the practical aspects of integrating psilocybin into contemporary medical practices, discussing the potential frameworks and guidelines that would govern its use. They explore what the future might hold for patients and practitioners alike as they stand on the cusp of a revolutionary shift in mental health treatment.
Whether you're a healthcare professional keen on the latest developments in medical research or someone interested in the evolving landscape of mental health treatment, this episode promises to be a rich source of information and insight. Tune in to be informed and to foster a deeper understanding of the promising horizon that psilocybin research is unveiling in the medical community.
In this Ryan sits down with Dr. Richard Dart MD, PhD. He is the lead author of the recently released "Management of Acetaminophen Poisoning in the US and Canada Consensus Statement" from the American Academy of Clinical Toxicology, American College of Medical Toxicology, Americans Poisons Centers, and the Canadian Association of Poison Centers. Listen to be informed on the most recent treatment recommendations. They dive in to the definitions established by the guideline and notable treatment recommendations, dissecting the ratinonale for each desiscion point and how to apply the guidelines. A mini episode was released along side this episode that is a high yield review of major treatment recommendations and definitions estabilished by the consensus statement.
>7.5 g in 24 h was criteria for Rumack Matthew nomogram
Consensus statement
Adult overdose at 10g/d or 200 mg/kg/d in <24 hours= potentially toxic
Pediatric <6 year at 150 mg/kg/d in <24 h = potentially toxic
Repeated Supra Therapeutic Ingestion (RSTI)
Overdose "dose"
Repeated dosing totaling
6g/d or 150 mg/kg/day x 24-48 h = potential toxic
4g/d or 100 mg/kg/day x >48 h = potential toxic (Recognize this means some people could be toxic at therapeutic dosing, but if they do not have symptoms not likely)
High risk ingestion
Reported dose >30 grams OR
[APAP] 2 x Rummack-Matthew nomogram treatment line
NAC stopping criteria
APAP<10
INR<2
AST/ALT Normal for patient or decreased by 25-50%
Patient clinically well
Notable treatment recommendations
RSTI
If patient has history of RSTI (>6 g x 24-48 h, >4 g x >48 hours) AND signs of APAP toxicity (vomiting, RUQ abd pain, AMS)
Treat if APAP >20 ug/ml OR AST/ALT elevated
Acute
Non-detectable [APAP] between 2 and 4 hours excludes ingestion
Start treatment with NAC if unable to plot on nomogram by 8 hours
NAC dose
“Higher dose” NAC (undefined) for high risk ingestion
Minimum NAC regimen should include 300 mg/kg orally or within 20-24 hours
CAP NAC dose at 100 kg (this was known with PO, but IV there was always some question since it delivers less overall)
Unique scenarios
Line crossers
APAP with anticholinergic or opioid
If 1st concentration below treatment line repeat in 4-6 hours
APAP Extended release
If 1st concentration below treatment line @ 4-12 hours, repeat in 4-6 hours
Dialysis-
Dialyze If APAP >900 w/ AMS or acidosis.
NAC IV rate during HD 12.5 mg/kg/hr minimum. No dose change for PO (not new but good reminders)
Consult liver transplant for rapid AST/ALT inc w/ coagulopathy, AMS, or mulistytem organ failure
The addition of fomepizole to acetylcysteine in the treatment of serious acetaminophen ingestions has been proposed. The panel concluded that the data available did not support a standard recommendation. As for any complicated or serious acetaminophen poisoning, a PC or clinical toxicologist should be consulted.
High Yield Highlight-Consensus Statement on Management of Acetaminophen Poisoning in the US and Canada
18 août 2023
00:13:11
This episode is a a high yield "just the facts" break down of the recently released "Management of Acetaminophen Poisoning in the US and Canada Consensus Statement" from the American Academy of Clinical Toxicology, American College of Medical Toxicology, Americans Poisons Centers, and the Canadian Association of Poison Centers. Listen to be informed on the most recent treatment recommendations. This was released alongside a full interview with the consensus statement corresponding author Dr. Richard Dart MD, PhD. Be sure to check out the full interview to hear it straight from the source! (link in show notes).
Start treatment with NAC if unable to plot on nomogram by 8 hours
NAC dose
“Higher dose” NAC (undefined) for high risk ingestion
Minimum NAC regimen should include 300 mg/kg orally or within 20-24 hours
CAP NAC dose at 100 kg (this was known with PO, but IV there was always some question since it delivers less overall)
Unique scenarios
Line crossers
APAP with anticholinergic or opioid
If 1st concentration below treatment line repeat in 4-6 hours
APAP Extended release
If 1st concentration below treatment line @ 4-12 hours, repeat in 4-6 hours
Dialysis-
Dialyze If APAP >900 w/ AMS or acidosis.
NAC IV rate during HD 12.5 mg/kg/hr minimum. No dose change for PO (not new but good reminders)
Consult liver transplant for rapid AST/ALT inc w/ coagulopathy, AMS, or mulistytem organ failure
The addition of fomepizole to acetylcysteine in the treatment of serious acetaminophen ingestions has been proposed. The panel concluded that the data available did not support a standard recommendation. As for any complicated or serious acetaminophen poisoning, a PC or clinical toxicologist should be consulted.
Toxicologists vs the Internet (#9) With Guest Dr Frank Paloucek PharmD DABAT FAACT
09 août 2023
01:28:32
Dr. Frank Paloucek, PharmD, DABAT (@itsalltox) joins the show. He was one of the very first emergency medicine pharmacists and one of the original board-certified clinical toxicologists (DABAT). He is now a proudly retired professor emeritus at The Univeristy of Illinois at Chicago. In his tenure there he spent nearly 20 years as the program director for their clinical pharmacy residency, was an integral part of the Toxikon Consortium toxicology fellowship, and coauthored the text book "Poisoning and Toxicology Handbook (Poisoning and Toxicology Handbook (Leiken & Paloucek's)) 4th Edition. Frank and Ryan kick off the show hearing about Frank's fledgling years working in an emergency department without EM attendings. Then they bust some toxicology myths (do you REALLY need BAL before Calcium disodium edetate in severe lead poisoning? Frank thinks no...) before jumping into solving some toxic cases. Finally, the episode ends with Frank and Ryan solving a case of poisoned AI. They ask GPT to take on the role of a poisoned patient and work together to identify the culprit. Enjoy and don't forget to leave a review.
The Undead Patient: The Complexity of Brain Death Determination in Drug Overdose
06 juin 2023
01:17:04
In this episode Ryan explores the concept of brain death and the implications of drug overdoses causing false positive diagnosis of brain death. He is joined by an author of the ACMT Position statement on brain death in overdose (Dr. Andrew Stolbach MD) as well as authors of two case reports (neuro critical care physician Dr. Ranier Reyes and emergency physician Dr. Doug Stranges) involving bupropion where patients had absent brain stem reflexes after overdose but made a full neurologic recovery. We delve into the criteria used to determine brain death and the challenges faced by families and healthcare professionals when dealing with this sensitive topic.
00:00-19:00 Introduction to brain death guidelines
19:00-28:00 Introduction to limitations in guidelines regarding overdose
28:30-38:00 Interview with ACMT Position statement author
39:00- End- Interview with Bupropion brain death mimic authors and summary
Toxicologists vs the Internet (#8) With Guest Dr Adam Blumenberg MD
12 avr. 2023
01:30:25
Dr. Adam Blumenberg, MD (@ABlumenbergMD) Join's the show. He is an emergency medicine physician, medical toxicologist, and Assistant Professor at Columbia University Medical Center in New York City. He hosts his own toxicology youtube series (www.ToxicHistory.com) and has developed multiple free medical education software programs in toxicology (www.toxicrunner.net) and medical simulation (www.medsimstudio.com). Most impressively, he has produced his own free base lidocaine crystals on a stove top, if you ask nicely he might just loan you one. He joins the show to sleuth the cause of fatal poisoning cases and tackle internet questions from reddit.com/r/askdrugs
High yield highlight- Managing a Bupropion overdose
26 févr. 2023
00:07:07
Ready for a high-octane dose of knowledge? 🔥🧠 Ryan's got you covered with this electrifying mini-episode on managing a bupropion overdose! 💊💥 Beware - there are plenty of pitfalls you'll want to avoid. Check out the full episode and other mini-episodes for even more tips and tricks! 🎧👀
Bupropion is the #1 antidepressant cause of major (life threatening) reported to U.S. Poison Centers
Aggressive whole bowel irrigation or charcoal may be indicated if large ingestion
Supportive care
Intubation if airway compromised
Benzodiazepine for agitation
Benzodiazepines and GABA-ergic AED's for status epileptics
Tachycardia, tremor, and agitation are risk factor for seizures
Tachycardia may be masked by alpha 2 agonist co ingestions
Seizures may occur 24 hour out
Sodium bicarbonate for wide QRS (it may be refractory)
Inodilators and vasopressors for cardiogenic shock
ECMO for refractory shock or arrhythmia
Awareness that severe bupropion toxicity can mimic brain death
send analytical confirmation of bupropion if possible to rule out confounding
Enhanced elimination
limited options due to protein binding, not routine
Focused antidote
Consider IV fat emulsion if the patient is peri arrest
Observation times
Talk to a toxicolleague about observation times, decontamination, and use of invasive therapies to avoid falling into a trap
A Prescription for Heartache (& Seizures) (Bupropion)
15 févr. 2023
01:30:40
What do bath salts, face eating zombies, and antidepressants have in common? In this episode Ryan has a number of guests (Dr Filip, Dr Olives, Dr Reyes) join to discuss a unique heart breaking poisoning that is now the number one cause of major life threatening effects in antidepressant overdose in the United States. Check out the mini episodes for more!
This antidepressant is the #1 cause of major (life threatening) effects in overdose reported to U.S. Poison Centers
Abstract 1: Vasodilation in patients with calcium channel blocker poisoning treated with high dose insulin: a comparison of amlodipine versus non-dihydropyridines
Toxicologists vs the Internet (#5) With Guest Dr Howard Greller MD (Sirius XM Doctor Radio Emergency Medicine Show, Dantastic Mr Tox & Howard, Tox & Hound)
02 mars 2022
01:21:49
Music from Pixabay
Additional information on toxins from fatal poisoning cases
Where is Episode 13 ? Bonus Episodes AND Next Episode Guest Dr. Howard Greller MD (Sirius XM Doctor Radio Emergency Medicine Show, Dantastic Mr Tox & Howard, Tox & Hound),
02 févr. 2022
00:09:04
No episode today. Head here for the live radio show!
Join us next show for Dr. Howard Greller of Sirius XM Doctor Radio, Dantastic Mr Tox & Howard, and Tox & Hound
Used by people to make tonic water, treat restless legs, or viruses
Prescription quinoline derivatives may cause cause similar effects
Quinine
Quinidine
Hydroxychloroquine
Chloroquine
Clinical effects
Dizzy
Flushed
Head ache
Tinnitus
Potential for vision loss
Laboratory assessment
Hypoglycemia
Hypokalemia
Long QRS
Treatment
Supportive care for ABCs
Potential role for epinephrine as preferred pressor from animal data and chloroquine data
Correct endocrine/metabolic abnormalities
Hypertonic sodium for wide QRS (be careful of worsening hypokalemia)
Consider multi dose activated charcoal
More on toxicity/studies from the episodes
Incidence of caridac arryhmias in patients taking quinine alone
Padmaja UK, Adhikari P, Periera P. Experience with quinine in falciparum malaria. Indian J Med Sci. 1999 Apr;53(4):153-7. PMID: 10695226.
Negative inotropic effects of quinidine
Hoffmeister HM, Hepp A, Seipel L. Negative inotropic effect of class-I-antiarrhythmic drugs: comparison of flecainide with disopyramide and quinidine. Eur Heart J. 1987 Oct;8(10):1126-32. doi: 10.1093/oxfordjournals.eurheartj.a062178. PMID: 3119341
Occular toxicity, can be permanent
Treatment is debated, not clear what is preferred , HBO used often
Vision may recover centrally first, than peripheral
Jarboe JK, Hallworth R. The effect of quinine on outer hair cell shape, compliance and force. Hear Res. 1999 Jun;132(1-2):43-50. doi: 10.1016/s0378-5955(99)00031-3. PMID: 10392546.
Toxicologists vs The Internet (#1) With Guest Dr. Matthew Stanton PharmD, DABAT
04 nov. 2020
01:07:32
Article authored by Ryan and Matt regarding potential toxicity of vitamin e acetate in THC vape cartridges
https://pubmed.ncbi.nlm.nih.gov/32451600/
https://pubmed.ncbi.nlm.nih.gov/33528766/
News article about the man arrested 1 floor below our Host where co-author of above paper is quouted. for selling vape cartridges
Mini Episode: The Saga of the Cardiac Action Potential
26 août 2020
00:15:27
Action potential
Sodium/Potassium ATPase pumps create more positively charged ions outside the cell than inside the cell, this creates a relative negative charge in the cell
Phase 4- Resting (~ -90 mv)
Phase 0- Sodium enters the cell (+10 mv)
Phase 1- Potassium efflux from cell as now there is no negative charge holding it in (0 mv)
Phase 2- Calcium channels open and allow calcium in, calcium triggers the ryandoine receptor and allows for calcium dependent calcium release from the sarcoplasmic reticulum occurs
Phase 3- Potassium continues to leave the cell allowing return to -90 mv
Mini episode: Early After Depolarizations and Experimental Mechanisms of Torsades
Fun theories about co evolution of PGP and CYP https://pubmed.ncbi.nlm.nih.gov/10837556/
Inhibition of sodium channels, and to a higher affinity, Human Ether a Go-Go Related (HERG) channel leads to prolonged repolarization (9)
IC50 for HERG Ikr ~ 40 nm/l (1908 ng/dl), inhibits as low as 10 nm/l (10)
Case reports of conduction disturbance with level of 22 ng/ml (14)
Levels in fatalities vary but reported as high as 270 ng/ml in some studies (15)
Prolonged re polarization leads to torsades
Early after depolarizations may trigger, which are then propagated torsades via re entrant rhythms (11)
Treatment
ACMT loperamide guidelines (12)
Supportive care
Arrhythmia management
Torsades (13)
Electrical cardioversion (terminates re entrant rhythm)
Magnesium (prevents early after depolarization)
Target Mg >2 and K >4
Lidocaine-> Recommended in 2006 Sudden cardiac death guidlines, not mentioned in 2017, however one of the only VT recommended antiarryhtmics that do not prolong QTc (others, sotalol, amiodarone, and procainamide, do)
If preceded by bradycardia, Overdrive pacing with isoproterenol to target HR~ 100
Beta blockers are recommended in patients with LQTS
Miller H, Panahi L, Tapia D, Tran A, Bowman JD. Loperamide misuse and abuse. J Am Pharm Assoc (2003). 2017;57(2S):S45eS50.
Feldman R, Everton E. National assessment of pharmacist awareness of loperamide abuse and ability to restrict sale if abuse is suspected [published online ahead of print, 2020 Jul 5]. J Am Pharm Assoc (2003). 2020;S1544-3191(20)30264-8. doi:10.1016/j.japh.2020.05.021
Eggleston W, Marraffa JM, Stork CM, et al. Notes from the Field: Cardiac Dysrhythmias After Loperamide Abuse — New York, 2008–2016. MMWR Morb Mortal Wkly Rep 2016;65:1276–1277. DOI: http://dx.doi.org/10.15585/mmwr.mm6545a7
Kang J, Compton DR, Vaz RJ, Rampe D. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(10):1133-1137. doi:10.1007/s00210-016-1286-7
Klein MG, Haigney MCP, Mehler PS, Fatima N, Flagg TP, Krantz MJ. Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide. JACC Clin Electrophysiol. 2016;2(7):784-789. doi:10.1016/j.jacep.2016.07.008
Eggleston W, Palmer R, Dubé PA, et al. Loperamide toxicity: recommendations for patient monitoring and management. Clin Toxicol (Phila). 2020;58(5):355-359. doi:10.1080/15563650.2019.1681443
Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society [published correction appears in J Am Coll Cardiol. 2018 Oct 2;72(14):1760]. J Am Coll Cardiol. 2018;72(14):e91-e220. doi:10.1016/j.jacc.2017.10.054
Marraffa JM, Holland MG, Sullivan RW, et al. Cardiac conduction disturbance after loperamide abuse. Clin Toxicol (Phila). 2014;52(9):952-957. doi:10.3109/15563650.2014.969371
Miller H, Panahi L, Tapia D, Tran A, Bowman JD. Loperamide misuse and abuse. J Am Pharm Assoc (2003). 2017;57(2S):S45-S50. doi:10.1016/j.japh.2016.12.079